- Correction
- Open access
- Published:
Correction: 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study
Trials volume 25, Article number: 646 (2024)
Correction: Trials 25, 332 (2024)
https://doi.org/10.1186/s13063-024-08102-z
Following the publication of the original article [1], we were notified that the authors would like to include the following disclosure statement:
“Dr. John Elfar holds a patent on 4-aminopyridine and has invested in startup company which intends to manufacture a pill alternative to the currently generic available pill utilized in John Elfar’s sponsored trials. Dr. Elfar served as the Chief Medical Officer at Solaxa (Solaxa.com) until October 2023 and now only serves as a founder.”
Reference
Ghazi, et al. 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study. Trials. 2024;25:332. https://doi.org/10.1186/s13063-024-08102-z.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ghazi, A., Osinski, T.L., Feng, C. et al. Correction: 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study. Trials 25, 646 (2024). https://doi.org/10.1186/s13063-024-08518-7
Published:
DOI: https://doi.org/10.1186/s13063-024-08518-7